1-5 of 5
Debbie-Ann N. Nathan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effective Treatment Of Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma With Autologous T Cells Genetically-Engineered To Express An Anti-CD19 Chimeric Antigen Receptor

James N. Kochenderfer, M.D., Mark E. Dudley, Ph.D., Sadik H. Kassim, Ph.D., Robert O. Carpenter, James C. Yang, MD, Giao Q. Phan, MD, Marybeth S. Hughes, MD, Richard M. Sherry, MD, Steven Feldman, Ph.D., David Spaner, MD, PhD, Debbie-Ann N. Nathan, RN, Kathleen E. Morton, RN, Mary Ann Toomey, RN, Steven A. Rosenberg, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 168.
https://doi.org/10.1182/blood.V122.21.168.168
Published: 2013
Journal Articles

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells

Clinical Trials & Observations
James N. Kochenderfer, Mark E. Dudley, Steven A. Feldman, Wyndham H. Wilson, David E. Spaner, Irina Maric, Maryalice Stetler-Stevenson, Giao Q. Phan, Marybeth S. Hughes, Richard M. Sherry, James C. Yang, Udai S. Kammula, Laura Devillier, Robert Carpenter, Debbie-Ann N. Nathan, Richard A. Morgan, Carolyn Laurencot, Steven A. Rosenberg
Journal: Blood
Blood (2012) 119 (12): 2709–2720.
https://doi.org/10.1182/blood-2011-10-384388
Published: 2012
Includes: Supplemental data
Journal Articles

B-Cell Depletion, Remissions of Malignancy, and Cytokine-Associated Toxicity in a Clinical Trial of T Cells Genetically-Engineered to Express An Anti-CD19 Chimeric Antigen Receptor

James N Kochenderfer, Mark E. Dudley, Steven Feldman, Wyndham H. Wilson, MD, PhD, David Spaner, Laura Devillier, Robert Carpenter, Debbie-Ann N. Nathan, Irina Maric, Richard A. Morgan, Steven A. Rosenberg
Journal: Blood
Blood (2011) 118 (21): 167.
https://doi.org/10.1182/blood.V118.21.167.167
Published: 2011
Journal Articles

A Phase I Clinical Trial of Treatment of B-Cell Malignancies with Autologous Anti-CD19-CAR-Transduced T Cells

James N. Kochenderfer, Mark E. Dudley, Maryalice Stetler-Stevenson, Wyndham H. Wilson, John E. Janik, Debbie-Ann N. Nathan, Irina Maric, Mark Raffeld, Steven A. Feldman, Richard A. Morgan, Steven A. Rosenberg
Journal: Blood
Blood (2010) 116 (21): 2865.
https://doi.org/10.1182/blood.V116.21.2865.2865
Published: 2010
Journal Articles

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

Brief Report
James N. Kochenderfer, Wyndham H. Wilson, John E. Janik, Mark E. Dudley, Maryalice Stetler-Stevenson, Steven A. Feldman, Irina Maric, Mark Raffeld, Debbie-Ann N. Nathan, Brock J. Lanier, Richard A. Morgan, Steven A. Rosenberg
Journal: Blood
Blood (2010) 116 (20): 4099–4102.
https://doi.org/10.1182/blood-2010-04-281931
Published: 2010
Includes: Supplemental data